AI Article Synopsis
- The text mentions a correction to a specific article identified by the DOI 10.3389/fimmu.2024.1354500.
- This correction likely addresses errors or updates to data or findings presented in the original article.
- Readers are encouraged to refer to the updated version to ensure they have the most accurate and reliable information.
Article Abstract
[This corrects the article DOI: 10.3389/fimmu.2024.1354500.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167446 | PMC |
| http://dx.doi.org/10.3389/fimmu.2024.1430718 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: Worldwide study on field trials of biotechnological crops: new promises but old policy hurdles.
Front Plant Sci
December 2024
Laboratory for Biotechnology, Institute of Field and Vegetable Crops, National Institute of Republic of Serbia, Novi Sad, Serbia.
[This corrects the article DOI: 10.3389/fpls.2024.
View Article and Find Full Text PDFCorrigendum to "LncRNA ZNF649-AS1 promotes trastuzumab resistance and TAM-dependent PD-L1 expression in breast cancer by regulating EXOC7 alternative splicing" [Archiv. Biochem. Biophys. 761 (2024) 110128].
Arch Biochem Biophys
December 2024
Department of General Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan Province, PR China; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, PR China. Electronic address:
Corrigendum: Alternative splicing: a new cause and potential therapeutic target in autoimmune disease.
Front Immunol
November 2024
Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Article Synopsis
- The article aims to correct some information related to the original study published under the DOI: 10.3389/fimmu.2021.713540.
- The corrections may involve updates or clarifications that enhance the accuracy of the findings.
- It’s important for ensuring that readers depend on precise and reliable scientific data.
Corrigendum to Peanut (Arachis hypogaea L.) seeds and by-products in metabolic syndrome and cardiovascular disorders: A systematic review of clinical studies Phytomedicine 123 (2024) 155170.
Phytomedicine
November 2024
Department of Biochemistry and Nutrition, School of Food and Technology of Marília (FATEC), Marília 17500-000, São Paulo, Brazil; Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Marília 17525-902, São Paulo, Brazil; Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Marília (UNIMAR), Marília 17525-902, São Paulo, Brazil. Electronic address:
Background: Cardiovascular diseases (CVDs) are the leading causes of death worldwide. The main risk factors are hypertension, diabetes, obesity, and increased serum lipids. The peanut (Arachis hypogaea L.
View Article and Find Full Text PDFCorrigendum to "Optimising a self-assembling peptide hydrogel as a Matrigel alternative for 3-dimensional mammary epithelial cell culture" [Biomater. Adv. volume 160, (2024) 213847].
Biomater Adv
February 2025
Wellcome Centre for Cell-Matrix Research, Oxford Road, Manchester M13 9PT, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!